Off-label use of aromatase inhibitors: An alternative in reproductive medicine and in other nonmammary diseases?;"Off-label-anwendung" von aromatasehemmern: Alternative in der reproduktionsmedizin und bei weiteren nichtsenologischen erkrankungen?

Gynakologische Endokrinologie

Volumn 6, Issue 4, 2008, Pages 221-228

  Bohlmann, M K ^a,d   Hornemann, A ^a   Weichert, J ^a   Stichtenoth, G ^b   Ortmann, J ^c   Diedrich, K ^a   Ludders D ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Universitätsklinik für Kinder und Jugendmedizin Lübeck

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Aromatase inhibitors; Hormone sensitive carcinoma; Infertility; Off label use; Puberty

Indexed keywords

ANASTROZOLE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CLOMIFENE; ESTRADIOL; ESTRONE; EXEMESTANE; GONADORELIN; LETROZOLE; METFORMIN; TAMOXIFEN; TESTOSTERONE;

ALBRIGHT SYNDROME; CONGENITAL ADRENAL HYPERPLASIA; DOPING; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; GYNECOMASTIA; HUMAN; LEIOMYOMA; MENOPAUSE; MYOMA; OFF LABEL DRUG USE; OVARY CARCINOMA; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; REPRODUCTION; REVIEW; TREATMENT INDICATION;

EID: 56549126060     PISSN: 16102894     EISSN: 16102908     Source Type: Journal    
DOI: 10.1007/s10304-008-0265-6     Document Type: Review

References (120)

1. Agorastos 2005 Eur J Obstet Gynecol Reprod Biol 118 239
2. Al-Fadhli 2006 Fertil Steril 85 161
3. Al-Omari 2004 Int J Gynaecol Obstet 85 289
4. Arlt 2007 Horm Res 68 158
5. Azim 2007 Fertil Steril 88 657
6. Azim 2007 J Clin Endocrinol Metab 92 2197
7. Badawy 2007 Reprod Biomed Online 14 559
8. Baysoy 2006 Reprod Biomed Online 13 208
9. Bedaiwy 2006 Hum Reprod 21 2838
10. Beck 2005 Cochrane Database Syst Rev 1 CD002249
11. Begum MR, Ferdous J, Begum A, Quadir E (2008) Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril (Epub ahead of print)
12. Bellone S, Shah HR, McKenney JK et al. (2008) Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole. Am J Obstet Gynecol (Epub ahead of print)
13. Berstein 2002 Eur J Obstet Gynecol Reprod Biol 105 161
14. Biljan 2005 Fertil Steril 84 S95
15. Boccardo 2005 J Clin Oncol 23 808
16. Bonfig 2007 J Clin Endocrinol Metab 92 1635
17. Boruban 2008 Eur J Cancer Prev 17 133
18. Bowman 2002 Clin Cancer Res 8 2233
19. Brito 2008 Arq Bras Endocrinol Metabol 52 18
20. Bulun 2001 J Steroid Biochem Mol Biol 79 19
21. Bulun 2002 Ann N Y Acad Sci 955 75
22. Bulun 2005 J Steroid Biochem Mol Biol 95 57
23. Burnett 2004 Gynecol Oncol 94 832
24. Casper 2006 J Clin Endocrinol Metab 91 760
25. Caruso-Nicoletti 1985 J Clin Endocrinol Metab 61 896
26. Clark 1989 J Androl 10 240
27. Cohen 2002 Clin Cancer Res 8 665
28. Crosignani 2006 Hum Reprod Update 12 179
29. Damiani D, Damiani D (2007) Pharmacological management of children with short stature: the role of aromatase inhibitors. J Pediatr (Rio J) 83: S172-177
30. del 2003 Gynecol Oncol 91 596
31. De 2008 Eur J Endocrinol 158 921
32. Demers 1993 J Steroid Biochem Mol Biol 44 687
33. de 2007 Curr Opin Endocrinol Diabetes Obes 14 235
34. de 2005 J Steroid Biochem Mol Biol 95 121
35. D 2003 Curr Opin Obstet Gynecol 15 243
36. Dobs 2005 J Urol 174 1737
37. Dörr 2007 Horm Res 68 93
38. Elizur 2008 Fertil Steril 89 1595
39. Elnashar 2006 Fertil Steril 85 511
40. Eugster 2001 J Pediatr 138 26
41. Fatemi 2005 Reprod Biomed Online 11 455
42. Feuillan 1993 J Clin Endocrinol Metab 77 647
43. Feuillan 2007 J Clin Endocrinol Metab 92 2100
44. Forman 2007 J Obstet Gynaecol Can 29 668
45. Freeman 2006 Gynecol Oncol 103 755
46. Garcia-Velasco 2005 Fertil Steril 84 82
47. Gill 2008 Can Fam Physician 54 353
48. Goswami 2004 Hum Reprod 19 2031
49. Gourley C, Smyth JF, Mackean M et al. (2006). Phase II study of letrozole in estrogen receptor (ER) positive relapsed epithelial ovarian cancer (EOC). J Clin Oncol (2006 ASCO Annual Meeting Proceedings, Atlanta, GA) 24 (Pt I) (Suppl. 18), Abstract #5025
50. Guzick 2007 Clin Obstet Gynecol 50 255
51. Handelsman 2006 J Clin Endocrinol Metab 91 1646
52. Handelsman 2008 Br J Pharmacol 154 598
53. Hero 2005 J Clin Endocrinol Metab 90 6396
54. Hero 2006 Clin Endocrinol 510
55. Hilário SG, Bozzini N, Borsari R, Baracat EC (2008) Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients. Fertil Steril Feb 2 (Epub ahead of print)
56. http://www.nada-bonn.de/fileadmin/user_upload/nada/Downloads/Listen/ 080403_Verbotsliste-WADA-2008-deutsch.pdf
57. Kafy 2007 Curr Opin Obstet Gynecol 19 248
58. Karaer 2004 Acta Obstet Gynecol Scand 83 699
59. Kaunitz 2007 Menopause 14 941
60. Kavanagh JJ, Hu W, Fu S et al. (2007) Anti-tumor activity of letrozole in patients with recurrent advanced low malignant potential or low grade serous ovarian tumors. J Clin Oncol (2007 ASCO Annual Meeting Proceedings, Chicago, IL) 25: No. 185 (Abstract 5582)
61. Krasner CN, Debernardo RL, Findley M et al. (2005) Phase II trial of anastrazole in combination with gefitinib in women with asymptomatic mullerian cancer. Proc Am Soc Clin Oncol Abstract #5063
62. Krauss 2007 Anticancer Res 27 3477
63. Kreher 2006 J Pediatr 149 416
64. Lantta 1984 Acta Obstet Gynecol Scand 63 497
65. Lee 2006 J Clin Oncol 24 2917
66. Lefevre 2006 Eur J Endocrinol 154 221
67. Li YF, Hu W, Fu SQ et al. (2007) Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer Sep 25 (Epub ahead of print)
68. Li 2008 Int J Gynaecol Obstet 100 10
69. Loves 2008 Eur J Endocrinol 158 741
70. Lumbroso 2004 J Clin Endocrinol Metab 89 2107
71. Ma 2004 Int J Gynecol Cancer 14 650
72. MacLusky 1987 Steroids 50 423
73. Mareck 2005 Rapid Commun Mass Spectrom 19 3689
74. Mareck 2006 Rapid Commun Mass Spectrom 20 1954
75. Mauras 2008 J Clin Endocrinol Metab 93 823
76. Merke 2001 Endocrinol Metab Clin North Am 30 121
77. Mieszczak 2007 Pediatr Endocrinol Rev 4 419
78. Mieszczak J, Lowe ES, Plourde P, Eugster EA (2008) The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. J Clin Endocrinol Metab Apr 8 (Epub ahead of print)
79. Miller 1997 Cancer Treat Rev 23 171
80. Mitwally 2001 Fertil Steril 75 305
81. Mok K, Juraskova I, Friedlander M (2008) The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions. Breast (Epub ahead of print)
82. Morishima 1995 J Clin Endocrinol Metab 80 3689
83. Nasu K, Tsuno A, Takai N, Narahara H (2008) A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole. Arch Gynecol Obstet Jun 4 (Epub ahead of print)
84. Nguyen 2006 Indian J Pediatr 73 89
85. Oktay 2006 J Clin Oncol 24 4221
86. Patwardhan 2008 BJOG 115 818
87. Papadimitriou 2004 Oncology 66 112
88. Papadopoulou M, Doula S, Kitsios K et al. (2006) A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment. Hormones (Athens) 5: 205-209
89. Pavlovich 2001 J Urol 165 837
90. Plourde 2004 J Clin Endocrinol Metab 89 4428
91. Polyzos 2008 Fertil Steril 89 278
92. Raman 2002 J Urol 167 624
93. Rao 2005 Curr Treat Options Oncol 6 97
94. Razzi 2004 BJOG 111 182
95. Reich 2007 Curr Opin Oncol 19 347
96. Reiter 2005 Pediatr Endocrinol Rev 3 77
97. Remorgida 2007 Aust N Z J Obstet Gynaecol 47 222
98. Richardson 2007 J Sex Med 4 502
99. Rivera 2004 J Clin Endocrinol Metab 89 3183
100. Rose 2000 Gynecol Oncol 78 212
101. Roth 2008 Nat Clin Pract Endocrinol Metab 4 415
102. Sallmen 2006 Epidemiology 17 520
103. Santen 2002 J Clin Endocrinol Metab 87 3007
104. Schiff 2005 J Clin Endocrinol Metab 90 6263
105. Shulman 2008 Pediatrics 121 e975
106. Smith 1994 N Engl J Med 331 1056
107. Smyth 2007 Clin Cancer Res 13 3617
108. Sohrabvand 2006 Hum Reprod 21 1432
109. Spano 2003 Med Oncol 20 87
110. Takayama 1998 Fertil Steril 69 709
111. Tchekmedyian NS, Liem AK, Quan ET et al. (2006) Aromatase inhibitor therapy for estrogen receptor positive ovarian cancer. J Clin Oncol (2006 ASCO Annual Meeting Proceedings, Atlanta, GA) 24: No. 185 (Abstract 15038)
112. Thigpen 1999 J Clin Oncol 17 1736
113. Tredway 2004 Fertil Steril 82 1587
114. Tulandi 2006 Fertil Steril 85 1761
115. Varelas 2007 Obstet Gynecol 110 643
116. Verma S, Alhayki M, Le T et al. (2006) Phase II study of exemestane (E) in refractory ovarian cancer (ROC). J Clin Oncol (2006 ASCO Annual Meeting, Atlanta, GA) 24, Abstract #5026
117. Walenkamp 2008 J Clin Endocrinol Metab 93 204
118. Wickman 2001 Lancet 357 1743
119. Verpoest 2006 Reprod Biomed Online 13 166
120. Zhou 2005 Pediatrics 115 e245